EDAP TMS (EDAP) Met with U.S. FDA Over Prostate Cancer Trial Recommendations
Tweet Send to a Friend
EDAP TMS SA (NASDAQ: EDAP), the global leader in therapeutic ultrasound, announced that the Company attended the Gastroenterology and Urology ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


